Sabre Corp quarterly report, Q3 FY2023

Sabre Corporation — Form 10-Q Summary

Reporting period: Quarter and nine months ended September 30, 2023. Sabre provides travel distribution and technology through Travel Solutions and Hospitality Solutions; much of its revenue depends on travel transaction volumes.

Financial performance

MetricQ3 2023Q3 2022Nine months 2023Nine months 2022
Revenue$740.5 million$663.4 million$2,220.7 million$1,905.8 million
Operating income (loss)$52.2 million$(56.5) million$9.8 million$(206.3) million
Net loss attributable to Sabre$(208.3) million$(135.4) million$(431.1) million$(275.4) million
Adjusted EBITDA$110.2 million$34.3 million$241.3 million$63.9 million
Free cash flowNot provided for the quarterNot provided for the quarter$(108.4) million$(368.2) million

Q3 operating margin was approximately 7.0%, versus approximately negative 8.5% a year earlier. Revenue increased 12% in Q3 and 17% year to date. Despite stronger operating results, higher financing costs and debt-extinguishment charges contributed to larger GAAP net losses. Q3 net interest expense rose 55% to $119.4 million; the quarter included a $121.1 million debt-extinguishment loss. Year-to-date net interest expense rose 59% to $325.3 million.

Business trends: Q3 Travel Solutions revenue rose 11% to $671.9 million; Distribution revenue benefited from 12% more direct billable bookings and improved international and corporate booking mix, while IT Solutions revenue declined 15%, primarily from customer de-migrations. Hospitality Solutions revenue increased 16% to $78.6 million, with SynXis transaction volumes up 7%. For the nine months, direct billable bookings increased 23%, passengers boarded increased 10%, and Hospitality central-reservation transactions increased 11%.

Cash, debt and liquidity

  • Cash and cash equivalents were $601.6 million at September 30, 2023, down from $794.9 million at December 31, 2022; restricted cash was $21.0 million.
  • Cash used in operations was $39.8 million for the first nine months, compared with $314.8 million used in the prior-year period. Capital expenditures were $68.6 million; reported free cash flow was negative $108.4 million.
  • Balance-sheet debt was $4.821 billion, net of issuance costs and discounts, versus $4.741 billion at year-end 2022. Face value was $4.955 billion. Current debt was $4.0 million and long-term debt was $4.817 billion.
  • Sabre had $130 million outstanding on its receivables facility and approximately $9 million of remaining borrowing availability. Management stated that cash on hand exceeded cumulative debt maturities through the end of 2026 and believed available resources could fund requirements for at least 12 months; it also cautioned that liquidity needs depend on uncertain travel recovery and other factors.
  • Debt refinancing and exchange activity extended some maturities but increased financing costs. The new 2028 term loan carries a floating rate, with a 13% initial rate when interest is paid-in-kind; Sabre elected to capitalize interest, adding $26 million to principal during the first nine months. Management reported compliance with debt covenants at quarter-end.

Material changes, outlook and risks

  • Cost reduction: Sabre recorded $56.4 million of restructuring charges through September, with approximately $70 million expected for 2023. Management estimates the plan will reduce annual operating expense by approximately $200 million; most expected cash disbursements were to occur in 2023.
  • Outlook and investment: No specific revenue or earnings guidance is stated in the provided filing text. Management expected 2023 capital expenditures of approximately $80 million and expected to be a U.S. federal cash taxpayer in 2023, with potential use of net operating loss carryforwards.
  • Debt exchange: A September exchange replaced approximately $853 million of 2025 notes with 8.625% secured notes due 2027. Fees, principally $115 million in exchange fees, drove the $121 million Q3 extinguishment loss. A separate June refinancing included a $700 million term loan, with proceeds used mainly to repurchase 2025 notes and some term loans.
  • Equity: The 6.50% mandatory convertible preferred stock converted on September 1 into approximately 47 million common shares, increasing common shares outstanding. The share repurchase program remained suspended.
  • Litigation and contingencies: US Airways seeks approximately $139 million in attorneys’ fees and costs following a nominal damages award; Sabre disputes the request. The filing says an award could require financing depending on its size. Indian tax claims could total approximately $22 million if authorities prevailed on all claims; no liability was recorded. Sabre also accrued $11 million in the first nine months for other tax matters.
  • Other risks: Management cited air-travel volume uncertainty, customer de-migrations, airline pricing and incentive-cost pressure, high leverage and variable-rate exposure, and competitive and technology-investment demands. An unauthorized actor extracted company data in Q3; the investigation was ongoing, with no material financial impact identified to date, but future costs or other consequences were not ruled out. Russian regulatory changes continue to limit certain services and weigh on results.

Key facts for investors to verify

  • Whether travel booking growth persists and offsets customer de-migrations, especially in IT Solutions and Russia-affected business.
  • Whether operating cash flow improves enough to cover capital spending, interest and other obligations, and whether the stated liquidity outlook remains supportable.
  • The actual cash cost of debt refinancing, future interest expense, floating-rate exposure and compliance with covenants.
  • The final US Airways attorneys’ fee award, other tax or legal outcomes, and potential costs or liabilities from the cybersecurity incident.
  • Whether the cost-reduction plan delivers the expected annual savings and whether implementation causes additional disruption or charges.
  • The effect of the preferred-stock conversion and any further share issuance on common-stock dilution.